Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34508
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPerera, D-
dc.contributor.authorVogrin, S-
dc.contributor.authorKhumra, Sharmila-
dc.contributor.authorMotaganahalli, S-
dc.contributor.authorBatrouney, A-
dc.contributor.authorUrbancic, K-
dc.contributor.authorDevchand, M-
dc.contributor.authorMitri, E-
dc.contributor.authorClements, R-
dc.contributor.authorNunn, A-
dc.contributor.authorReynolds, G-
dc.contributor.authorTrubiano, Jason-
dc.date2023-
dc.date.accessioned2023-12-13T05:25:54Z-
dc.date.available2023-12-13T05:25:54Z-
dc.date.issued2023-12-
dc.identifier.citationJAC-Antimicrobial Resistance 2023-12; 5(6)en_US
dc.identifier.issn2632-1823-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34508-
dc.description.abstractIn patients with spinal cord injuries (SCIs), infections continue to be a leading cause of morbidity, mortality and hospital admission. This study evaluated the long-term impact of a weekly, multidisciplinary Spinal/Antimicrobial Stewardship (AMS) meeting for acute-care SCI inpatients, on antimicrobial prescribing over 3 years. A retrospective, longitudinal, pre-post comparison of antimicrobial prescribing was conducted at our tertiary hospital in Melbourne. Antimicrobial prescribing was audited in 6 month blocks pre- (25 April 2017 to 24 October 2017), immediately post- (27 March 2018 to 25 September 2018) and 3 years post-implementation (2 March 2021 to 31 August 2021). Antimicrobial orders for patients admitted under the spinal unit at the meeting time were included. The number of SCI patients prescribed an antimicrobial at the time of the weekly meeting decreased by 40% at 3 years post-implementation [incidence rate ratio (IRR) 0.63; 95% CI 0.51-0.79; P ≤ 0.001]. The overall number of antimicrobial orders decreased by over 22% at 3 years post-implementation (IRR 0.78; 95% CI 0.61-1.00; P = 0.052). A shorter antimicrobial order duration in the 3 year post-implementation period was observed (-28%; 95% CI -39% to -15%; P ≤ 0.001). This was most noticeable in IV orders at 3 years (-36%; 95% CI -51% to -16%; P = 0.001), and was also observed for oral orders at 3 years (-25%; 95% CI -38% to -10%; P = 0.003). Antimicrobial course duration (days) decreased for multiple indications: skin and soft tissue infections (-43%; 95% CI -67% to -1%; P = 0.045), pulmonary infections (-45%; 95% CI -67% to -9%; P = 0.022) and urinary infections (-31%; 95% CI -47% to -9%; P = 0.009). Ninety-day mortality rates were not impacted. This study showed that consistent, collaborative meetings between the Spinal and AMS teams can reduce antimicrobial exposure for acute-care SCI patients without adversely impacting 90 day mortality.en_US
dc.language.isoeng-
dc.titleImpact of a sustained, collaborative antimicrobial stewardship programme in spinal cord injury patients.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJAC-Antimicrobial Resistanceen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationDepartment of Medicine, St Vincent's Health, The University of Melbourne, 29 Regent Street, Fitzroy 3065, Victoria, Australia.en_US
dc.identifier.affiliationPharmacyen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Doherty Institute, University of Melbourne, 792 Elizabeth St, Melbourne 3000, Victoria, Australia.en_US
dc.identifier.affiliationVictorian Spinal Cord Serviceen_US
dc.identifier.affiliationNational Centre for Infections in Cancer, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne 3000, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3000, Victoria, Australia.en_US
dc.identifier.doi10.1093/jacamr/dlad111en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-6739-0424en_US
dc.identifier.orcid0000-0002-9275-578Xen_US
dc.identifier.orcid0000-0002-5111-6367en_US
dc.identifier.pubmedid38021039-
dc.description.volume5-
dc.description.issue6-
dc.description.startpagedlad111-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptPharmacy-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

90
checked on Mar 9, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.